Pharming shares hit by FDA's refusal to review Rhucin
Netherlands News
Shares in biotech firm Pharming were hit hard in Amsterdam on Monday following the US food and drug adminisration's refusal to accept the company´s drug Rhucin for review. Source: News from DutchNews.nl